PTU - Polskie Towarzystwo Urologiczne
list of articles:


Article published in Urologia Polska 1998/51/1.

authors

Piotr Radziszewski, Andrzej Borkowski
Katedra i Klinika Urologii AM w Warszawie
Kierownik Kliniki: prof. dr hab. n. med. A. Borkowski

keywords

urinary tract urine-voiding disorders treatment

references

  1. [1] Abrams, R, Schulman, C. C, Vaage, S. i wsp.: Tamsulosin, a selective
  2. ?lc-adrenoceptor antagonist, a randomized, controlled trial in patients with
  3. benign prostatic ?obstruction" (Symptomatic BPH). Br. J. Urol. 1995, 76,
  4. 325-336.
  5. [2] Andersson, K. E.: Current concepts in treatment of disorders of micturition.
  6. Drugs 1988, 35, 477-494.
  7. [3] Andersson, K. E.: Pharmacology of lower urinary tract smooth muscles and
  8. penile tissues. Pharm. Reviews 1993, 45, 253-307.
  9. [4] Andersson, K. E., Fovaeus, M., Morgan, E. i wsp.: Comparative effects of
  10. five different calcium channel blockers on the atropine resistant contractions
  11. in electrically stimulated rabbit urinary bladder. Neurol. Urodyn. 1986, 5,
  12. 579-586.
  13. [5] Awad, S., Downie, ]., Kiruluta, H.: Alpha adrenergic agents in urinary di-
  14. sorders of the proximal urethra. I. Stress incontinence. Br. J. Urol. 1978, 50,
  15. 332-335.
  16. [6] Awad, S. A.: Clinical use of betanechol. J. Urol. 1985, 134, 523-524.
  17. [7] Baggioni, I., Omot, J., Stewart, C. K.: The potent pressor effect ofphenylpro-
  18. panolamine in patients with autonomie impairment. J. Am. Med. Assoc. 1987,
  19. 258, 236-239.
  20. [8] Baltitude, M., Hills, N., Shuttelworth, K.: Clinical and experimental stu-
  21. dies on the action of Prostaglandins and their synthesis inhibitors on detrusor
  22. muscle in vitro and in vivo. Br. J. Urol. 1976, 48, 631-637.
  23. [9] Batra, S. C, Josif, S. C: Female urethra: a target for estrogen action. J. Urol.
  24. 1983, 129, 418-420.
  25. [10] Bergman, A, Stanczyk, F. Z., Lobio, R. A.: The role of Prostaglandins in de-
  26. trusor instability. Am. J. Obstet. Gynecol. 1991, 165, 1833-1836.
  27. [11] Briggs, R. S., Castleden, C. M., Asher, M. J.: The effect offlavoxate on unin-
  28. hibitun. in. hibit. ed detrusor contractions and urinary continence in the eldery.
  29. J. Urol. 1980, 123, 656-666.
  30. [12] Buzelin, J. M., Geffriaud-Ricouard, C, Delauche-Cavalier, M. C. i wsp.:
  31. A double blind, placebo-controlled trial of the efficacy and safety of sustained
  32. release alfuzosin in Symptomatic benign prostatie hyperplasia (BPH). J. Urol.
  33. 1995, 153 Suppl., 274A.
  34. [13] Castelden, C. M., George, C. E, Renwick, A. G. i wsp.: Imipraminę ?
  35. a possible alternative to current therapy for urinary incontinence in the eldery.
  36. J. Urol. 1981, 125, 218-320.
  37. [14] Christensen, M. M, Holme, J. B., Rasmussen, P. C. i wsp.: Doxazosin tre-
  38. atment in patients with prostatic obstruction. Scand. J. Urol. Nephrol. 1993,
  39. 27, 39-44.
  40. [15] Czernecki, J.: Indeks leków 1997. Środki medyczne i materiały farmaceutycz-
  41. ne zarejestrowane w Polsce. JWC Warszawa 1997.
  42. [16] Davidoff, R. A.: Antispasticity drugs: mechanism of action. Ann. Neurol. 1975,
  43. 17, 107-116.
  44. [17] Diokno, A. C, Lapides, J.: Action of oral and parenteral betanechol on decom-
  45. pensated bladder. Urology 1977, 10, 23-24.
  46. [18] Ek, A., Andersson, K. E., Gullberg, B. i wsp.: The effects of long-term treat-
  47. ment with norphedrin on stress incontinence and urethral dossure pressure pro.
  48. file. Scand. J. Urol. Nephrol. 1978, 12, 105-110.
  49. [19] Ekland, A., Sander, S.: Urodynamic study of emperonium bromide in bladder
  50. dysfunction. Scand. J. Urol. Nephrol. 1976, 10, 195199.
  51. [20] Elbadawi, A.: Functional anatomy of the organs of micturition. Urol. Clin.
  52. North America 1996, 23 (2), 177-210.
  53. [21] Elliott, R. A., Norman, R. I., Parker, S. G. i wsp.: Effect of treatment with
  54. calcium antagonists in vitro and in vivo on the contractile response of isolated
  55. rat and human detrusor muscle. Clin. Sci. 1996, 91 (4), 467474.
  56. [22] Fisher, C, Dioko, A., Lapides, J.: The anticholinergic effects of dicyclomine
  57. hydrochloride in uninhibited bladder dysfunction. J. Urol. 1978, 120, 328-329.
  58. [23] Florante, }., Leyson, }., Martin, B. i wsp.: Baclofen in the treatment of de-
  59. trussor-sphincter dyssynergy in spinal cord injury patients. J. Urol. 1980, 124,
  60. 82-84.
  61. [24] Gruneberg, A.: Treatment of motor urge incontinence with clerbuterol and fla-
  62. voxate hydrochloride. B. J. Obstet. Gyn. 1984, 91, 275-278.
  63. [25] Hackler, R., Broecker, B., Klein, R i wsp.: A clinical experience with dantro-
  64. lene sodium for external urinary sphincter hypertonicity in spinal cord injured
  65. patients. J. Urol. 1981, 124, 78-81.
  66. [26] Kiesswetter, H., Schober, W.: Lioresal in the tratment of neurogenic bladder
  67. dysfunction. Urol. Int. 1975, 30, 63-71.
  68. [27] Krane, L., Olsson, C: Phenoxybenmtzine in neurogenic bladder dysfunction.
  69. I. Clinical considerations. J. Urol. 1973a, 110, 650-653.
  70. [28] Maggi, C. A.: Capsaicin and primary afferent neurons: from basic Science to
  71. human therapy. J. Auton. Neuro. Syst. 1991, 33, 1-14.
  72. [29] McCallum, R., Albibi, R.: Metoclopramide: pharmacology and clinical appli-
  73. cation. Ann. Intern. Med. 1983, 98, 86-95.
  74. [30] Mitchel, W. C, Venable, D. D.: Effects of metoclopramide on detrusor func-
  75. tion. }. Urol. 1985, 134, 791-794.
  76. [31] Muskat, Y. , Bukovsky, I. , Schneider, D. i wsp.: The use of scopolamine in
  77. the treatment of detrusor instability. J. Urol. 1996, 156, 1989-1990.
  78. [32] Nitti, V. W.: Intravesical capsaicin for treatment of the neurogenic bladder.
  79. Lancet 1994, 343, 1448.
  80. [33] Obrink, A., Bunne, G.: The effect of alpha adrenergic stimulation in stress in-
  81. continence. Scand. J. Urol. Nephrol. 1978, 12, 205-208.
  82. [34] Podlewski, J. K., Chwalibogowska-Podlewska, A.: Leki zuspółczesnej tera-
  83. pii. Split Trading, Warszawa 1994.
  84. [35] Riccabona, M.: Conservative treatment of urine-voiding disorders due to
  85. a hypocontractile bladder. Dtch. Med. Wschr. 1981, 106, 1579-1582.
  86. [36] Rondot, P., Marchand, M. P., Dellatolas, G.: Spasmodic torticollis - re-
  87. view of 220 patients. Can. J. Neurol. Sci. 1991, 18, 143-151.
  88. [37] Schreiter, R, Fuchs, R, Stockamp, K.: Estrogenie sensitivity of alpha recep-
  89. tors in the urethral musculature. Urol. Int . 1976, 31, 13-19.
  90. [38] Shah, P. J. R., Abrams, R, Choa, R. G.: Distigmine bromide and postprosta-
  91. tectomy voiding. Br. J. Urol. 1983, 55, 229-232.
  92. [39] Szollar, S. M., Lee, S. M.: Intravesical oxybutynin for spinal cord injury pa-
  93. tients. Spinal Cord 1996, 34, 284-287.
  94. [40] Wein, A. J.: Classification of neurogenic voiding dysfunction. J. Urol. 1981,
  95. 125, 605-609.